DermTech Operating Income

DermTech (DMTK) currently reports a operating income of $-91M as of March 2024. That compares with $-120M in the prior-year period — up 24.3% year over year. Use the charts on this page to explore DermTech's operating income history and peer comparisons.

DermTech's operating income increased from $-120M to $-91M — a 24.3% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DermTech reported $-91M in operating income as of March 2024. That compares with $-120M in the prior-year period — up 24.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-91M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DermTech, and consider following DMTK for alerts when major investors trade the stock.

DermTech is classified in the Healthcare sector. On operating income, it currently shows $-91M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DMTK with unrelated industries.